European Commission grants orphan drug designation to XLRP gene therapy candidate June 9, 2016 No Comments
Ocular Therapeutix's phase III trial of Dextenza does not meet primary endpoint June 7, 2016 No Comments
RegeneRx Biopharmaceuticals and Lee's Pharmaceutical accelerate development of RGN-259 June 3, 2016 No Comments
QR-110 from ProQR Therapeutics receives U.S. and E.U. orphan drug designations June 2, 2016 No Comments
Eyegate Pharmaceuticals' EGP-437 shows positive response in phase Ib/IIa study June 2, 2016 No Comments
Humira receives CHMP positive opinion to treat certain forms of noninfectious uveitis May 30, 2016 No Comments
RSS